We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINA icon
2226
Winmark
WINA
$1.29B
$653K ﹤0.01%
3,700
+207
+6% +$34.9K
FLXN
2227
DELISTED
Flexion Therapeutics, Inc.
FLXN
$653K ﹤0.01%
47,659
+1,202
+3% +$14.3K
WSBF icon
2228
Waterstone Financial
WSBF
$377M
$652K ﹤0.01%
37,955
+2,853
+8% +$48.1K
TLRD
2229
DELISTED
Tailored Brands, Inc.
TLRD
$652K ﹤0.01%
148,281
+1,522
+1% +$7.71K
CCNE icon
2230
CNB Financial Corp
CCNE
$1.04B
$650K ﹤0.01%
22,663
+1,877
+9% +$51.6K
LQDT icon
2231
Liquidity Services
LQDT
$1.36B
$646K ﹤0.01%
87,269
+5,137
+6% +$35.5K
ACBI
2232
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$646K ﹤0.01%
37,261
+2,885
+8% +$50.1K
AXSM icon
2233
Axsome Therapeutics
AXSM
$10.9B
$644K ﹤0.01%
31,799
+525
+2% +$13.5K
PETQ
2234
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$644K ﹤0.01%
23,607
+247
+1% +$7.82K
PGEN icon
2235
Precigen
PGEN
$2.47B
$642K ﹤0.01%
112,321
+6,732
+6% +$45.7K
ACRE
2236
Ares Commercial Real Estate
ACRE
$266M
$637K ﹤0.01%
41,828
+3,589
+9% +$54.7K
TPIC
2237
DELISTED
TPI Composites
TPIC
$637K ﹤0.01%
33,979
-140
-0.4% -$2.99K
HTB
2238
HomeTrust Bancshares
HTB
$861M
$637K ﹤0.01%
24,429
+1,309
+6% +$33.4K
CYRX icon
2239
CryoPort
CYRX
$748M
$630K ﹤0.01%
38,543
+2,310
+6% +$46.3K
PI icon
2240
Impinj
PI
$5.19B
$628K ﹤0.01%
20,357
-5
-0% -$175
OPCH icon
2241
Option Care Health
OPCH
$3.53B
$626K ﹤0.01%
48,905
+3,762
+8% +$46.3K
JCAP
2242
DELISTED
Jernigan Capital, Inc.
JCAP
$625K ﹤0.01%
32,478
+3,588
+12% +$71.1K
RAD
2243
DELISTED
Rite Aid Corporation
RAD
$623K ﹤0.01%
89,617
+7,547
+9% +$54.2K
SNAP icon
2244
Snap
SNAP
$8.83B
$621K ﹤0.01%
39,287
-430
-1% -$6.89K
WIFI
2245
DELISTED
Boingo Wireless, Inc.
WIFI
$620K ﹤0.01%
55,853
-290
-0.5% -$4.08K
DMRC icon
2246
Digimarc Corp
DMRC
$164M
$619K ﹤0.01%
15,845
+739
+5% +$31.9K
EQBK icon
2247
Equity Bancshares
EQBK
$1.06B
$616K ﹤0.01%
22,995
+1,866
+9% +$48.9K
BHB icon
2248
Bar Harbor Bankshares
BHB
$675M
$614K ﹤0.01%
24,610
+2,099
+9% +$50.1K
KURA icon
2249
Kura Oncology
KURA
$826M
$614K ﹤0.01%
40,461
+2,649
+7% +$47.2K
WMK icon
2250
Weis Markets
WMK
$1.86B
$612K ﹤0.01%
16,041
-8,614
-35% -$328K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.